ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

LXRX Lexicon Pharmaceuticals Inc

1.595
-0.015 (-0.93%)
Last Updated: 11:57:23
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Lexicon Pharmaceuticals Inc LXRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.015 -0.93% 1.595 11:57:23
Open Price Low Price High Price Close Price Prev Close
1.62 1.56 1.63 1.61
more quote information »

Recent News

Date Time Source Heading
4/18/202408:00GLOBELexicon Pharmaceuticals to Host 2024 Investor Day
4/03/202408:00GLOBELexicon Pharmaceuticals to Participate in the 23rd Annual..
3/25/202409:20GLOBEClinical Data on the Impact of Sotagliflozin on Stroke and..
3/12/202408:00GLOBENew Post Hoc Analysis of inTandem3 Study Demonstrates..
3/11/202416:25EDGAR2Form PRE 14A - Other preliminary proxy statements
3/11/202407:26EDGAR2Form 8-K - Current report
3/11/202407:15GLOBELexicon Pharmaceuticals Reports Fourth Quarter..
3/11/202407:05GLOBELexicon Announces Oversubscribed $250 Million Private..
3/11/202407:00GLOBELexicon Preparing to Resubmit Sotagliflozin NDA for Type 1..
2/29/202416:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202416:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202416:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202416:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202416:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202416:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202416:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202416:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202416:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202407:00GLOBELexicon Pharmaceuticals Provides Business and Pipeline..
12/29/202317:29EDGAR2Form 8-K - Current report
12/29/202317:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/29/202316:04EDGAR2Form 8-K - Current report
12/21/202316:15GLOBELexicon Pharmaceuticals To Participate In The 42nd Annual..
11/30/202307:30GLOBELexicon Enrolls First Patient in Phase 2b Progress Study of..
11/22/202307:30GLOBELexicon Pharmaceuticals to Participate in the 35th Annual..
11/17/202316:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202317:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202314:10GLOBEINPEFA® (sotagliflozin) Use Associated With Early Clinical..
11/10/202316:01GLOBELexicon Pharmaceuticals to Participate in the Jefferies..
11/08/202316:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202307:22EDGAR2Form 8-K - Current report
11/08/202307:00GLOBELexicon Pharmaceuticals Reports Third Quarter 2023 Financial..
11/03/202309:00GLOBELexicon Pharmaceuticals to Host Third Quarter 2023 Financial..
11/02/202309:00GLOBEData on Early Clinical Benefit for INPEFA® (Sotagliflozin)..
11/01/202309:00GLOBEINPEFA® (Sotagliflozin) Receives Coverage From Express..
10/31/202316:01GLOBELexicon Strengthens Management Team With Two New Executives
10/30/202316:01GLOBENew Data Relating to Sotagliflozin to be Presented at the..
10/17/202316:01GLOBEData From Two Studies Demonstrating Positive Financial..
10/11/202316:06EDGAR2Form 8-K - Current report
10/11/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202316:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/11/202309:00GLOBEData Demonstrating Financial Impact of INPEFA®..
10/09/202316:01GLOBEINPEFA® (Sotagliflozin) Receives Preferred Formulary Status..
10/09/202308:00GLOBETom Garner Joins Lexicon as Senior Vice President and Chief..
9/28/202309:00GLOBELexicon to Present Post Hoc Analysis of Scored Clinical..
9/26/202309:00GLOBELexicon to Present Study Results Relating to Sotagliflozin..
9/14/202317:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/07/202316:30GLOBELexicon Pharmaceuticals to Participate in the H.C...

Your Recent History

Delayed Upgrade Clock